Community Ophthalmology Framework Published
Eye conditions such as age-related macular degeneration (AMD) and glaucoma will increase as the population ages. The number of patients receiving treatments for AMD in the Hospital Eye Service is already nearing capacity and those patients with glaucoma require life-long follow up. This means that the current service model is becoming unsustainable. To tackle this
Response to NICE announcing their positive draft final guidance for EYLEA® for the treatment of visual impairment due to diabetic macular oedema (DMO)
The Royal College of Ophthalmologists welcomes the draft Final Appraisal Determination (FAD) from NICE recommending EYLEA (aflibercept) as a treatment option for patients with visual impairment due to diabetic macular oedema (DMO) and a central retinal thickness of >400 micrometers. We hope that this decision will become final and that clinical commissioning groups will support
Sharing patient information between healthcare professionals – a joint statement from The Royal College of Ophthalmologists and College of Optometrists
People using health and social care services are entitled to expect that their personal information will remain confidential. However, people also expect professionals to share information with other members of the care team. Good sharing of information[1], when sharing is appropriate, is as important as maintaining confidentiality. Optometrists, as regulated professionals, are part of the
Annual Congress Sponsorship Scheme 2015
The Royal College of Ophthalmologists Scientific Committee and International Committee are offering up two complementary admissions to the Annual Congress to colleagues from developing countries. The ophthalmologists (a senior trainee or consultant) will be offered free registration to the entire Congress. This will be supported by a local ‘sponsor’ (RCOphth member) who will apply for